AI Can Design Antibodies Faster Than Anyone Can Check Them for Immune Risk. That Gap Is Starting to Close.
News Provided by Wall Street Investor on behalf of MindWalk Holdings Corp. AUSTIN, Texas, Oct. 21, 2026 (GLOBE NEWSWIRE) — Wall Street Investor News Commentary – Antibodies have become one of medicine’s most valuable drug classes, with 144 FDA-approved antibody drugs on the market as of August 2025 and global sales of more than $267 […]
We haven't written up this one. Financial Post has the full story — the link below goes straight to it.
